TY - JOUR
T1 - Suppression of the development of adjuvant arthritis by a conditioned aversive stimulus
AU - Lysle, Donald T.
AU - Luecken, Linda J.
AU - Maslonek, Kimberly A.
N1 - Funding Information:
This work was supported by a grant to Donald T. Lysle from the National Institute of Mental Health (MH46284). Address correspondence to Donald T. Lysle, Department of Psychology, Davie Hall, CB#3270, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-3270.
Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1992/3
Y1 - 1992/3
N2 - The present study evaluated the effect of a conditioned aversive stimulus (CS) on the development of adjuvant-induced arthritis in Lewis rats. Experiment 1 showed that presentation of a CS, on days 12, 14, and 16 following injection with adjuvant containing mycobacterium tuberculosis, resulted in a pronounced suppression of the development of arthritis as measured by a clinical disease severity rating scale and spleen weight. In contrast, presentation of the CS on days 0, 2, and 4 following injection did not have any effect on the development of arthritis. Experiment 2 showed that the suppression of adjuvant arthritis by exposure to the CS was blocked by administration of propranolol, a nonselective β-adrenergic receptor antagonist. These results demonstrate that a CS can alter the development of adjuvant-induced arthritis, but the effect is dependent upon the timing of the antigen exposure and the presentation of the CS. Moreover, the present findings suggest that blocking β-adrenergic receptors during presentations of the CS prevents the suppressive effect of the CS.
AB - The present study evaluated the effect of a conditioned aversive stimulus (CS) on the development of adjuvant-induced arthritis in Lewis rats. Experiment 1 showed that presentation of a CS, on days 12, 14, and 16 following injection with adjuvant containing mycobacterium tuberculosis, resulted in a pronounced suppression of the development of arthritis as measured by a clinical disease severity rating scale and spleen weight. In contrast, presentation of the CS on days 0, 2, and 4 following injection did not have any effect on the development of arthritis. Experiment 2 showed that the suppression of adjuvant arthritis by exposure to the CS was blocked by administration of propranolol, a nonselective β-adrenergic receptor antagonist. These results demonstrate that a CS can alter the development of adjuvant-induced arthritis, but the effect is dependent upon the timing of the antigen exposure and the presentation of the CS. Moreover, the present findings suggest that blocking β-adrenergic receptors during presentations of the CS prevents the suppressive effect of the CS.
UR - http://www.scopus.com/inward/record.url?scp=0026647883&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026647883&partnerID=8YFLogxK
U2 - 10.1016/0889-1591(92)90060-2
DO - 10.1016/0889-1591(92)90060-2
M3 - Article
C2 - 1315181
AN - SCOPUS:0026647883
SN - 0889-1591
VL - 6
SP - 64
EP - 73
JO - Brain, Behavior, and Immunity
JF - Brain, Behavior, and Immunity
IS - 1
ER -